MicroRNA-208a Dysregulates Apoptosis Genes Expression and Promotes Cardiomyocyte Apoptosis during Ischemia and Its Silencing Improves Cardiac Function after Myocardial Infarction

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Tony, Hasahya ^a   Meng, Kai ^b   Wu, Bangwei ^c   Yu, Aijia ^a   Zeng, Qiutang ^a   Yu, Kunwu ^a   Zhong, Yucheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; EOSIN; HEMATOXYLIN; MICRORNA; MICRORNA 208A; UNCLASSIFIED DRUG; MIRN208 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENE ONTOLOGY; GENETIC TRANSFECTION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SHAM PROCEDURE; TUNEL ASSAY; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL CULTURE; FIBROSIS; GENE EXPRESSION REGULATION; GENE SILENCING; HEART MUSCLE ISCHEMIA; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELLS, CULTURED; FIBROSIS; GENE EXPRESSION REGULATION; GENE SILENCING; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC;

EID: 84949219381     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/479123     Document Type: Article

References (32)

1. E. Palojoki, A. Saraste, A. Eriksson et al., "Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 280, no. 6, pp. H2726-H2731, 2001.
2. A. Diwan, M. Krenz, F. M. Syed et al., "Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice, " The Journal of Clinical Investigation, vol. 117, no. 10, pp. 2825-2833, 2007.
3. D. Engel, R. Peshock, R. C. Armstong, N. Sivasubramanian, and D. L. Mann, "Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 287, no. 3, pp. H1303-H1311, 2004.
4. L.-A. Macfarlane and P. R. Murphy, "MicroRNA: biogenesis, function and role in cancer, " Current Genomics, vol. 11, no. 7, pp. 537-561, 2010.
5. M. Ha and V. N. Kim, "Regulation of microRNA biogenesis, " Nature Reviews Molecular Cell Biology, vol. 15, no. 8, pp. 509-524, 2014.
6. T. E. Callis, K. Pandya, H. Y. Seok et al., "MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice, " The Journal of Clinical Investigation, vol. 119, no. 9, pp. 2772-2786, 2009.
7. R. L. Montgomery, T. G. Hullinger, H. M. Semus et al., "Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure, " Circulation, vol. 124, no. 14, pp. 1537-1547, 2011.
8. E. vanRooij, D. Quiat, B. A. Johnson et al., "Afamily ofmicroRNAs encoded by myosin genes governs myosin expression and muscle performance, " Developmental Cell, vol. 17, no. 5, pp. 662-673, 2009.
9. E. Van Rooij, L. B. Sutherland, X. Qi, J. A. Richardson, J. Hill, and E. N. Olson, "Control of stress-dependent cardiac growth and gene expression by a microRNA, " Science, vol. 316, no. 5824, pp. 575-579, 2007.
10. E. Bostjancic, N. Zidar, D. Stajer, and D. Glavac, "MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction, " Cardiology, vol. 115, no. 3, pp. 163-169, 2010.
11. M. Satoh, Y. Minami, Y. Takahashi, T. Tabuchi, and M. Nakamura, "Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy, " Journal of Cardiac Failure, vol. 16, no. 5, pp. 404-410, 2010.
12. M. Ieda, T. Tsuchihashi, K. N. Ivey et al., "Cardiac fibroblasts regulate myocardial proliferation through 1 integrin signaling, " Developmental Cell, vol. 16, no. 2, pp. 233-244, 2009.
13. A. Aries, P. Paradis, C. Lefebvre, R. J. Schwartz, and M. Nemer, "Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 18, pp. 6975-6980, 2004.
14. D. W. Huang, B. T. Sherman, and R. A. Lempicki, "Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, " Nature Protocols, vol. 4, no. 1, pp. 44-57, 2009.
15. D. W. Huang, B. T. Sherman, and R. A. Lempicki, "Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists, " Nucleic Acids Research, vol. 37, no. 1, pp. 1-13, 2009.
16. A. Nagashima, R. Watanabe, M. Ogawa et al., "Different roles of PPAR-activity on physiological and pathological alteration after myocardial ischemia, " Journal of Cardiovascular Pharmacology, vol. 60, no. 2, pp. 158-164, 2012.
17. M. T. Crow, K. Mani, Y.-J. Nam, and R. N. Kitsis, "The mitochondrial death pathway and cardiac myocyte apoptosis, " Circulation Research, vol. 95, no. 10, pp. 957-970, 2004.
18. L. Qian, L.W. Van Laake, Y. Huang, S. Liu, M. F. Wendland, and D. Srivastava, "miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes, " Journal of Experimental Medicine, vol. 208, no. 3, pp. 549-560, 2011.
19. B. A. French and C. M. Kramer, "Mechanisms of postinfarct left ventricular remodeling, " Drug Discovery Today: Disease Mechanisms, vol. 4, no. 3, pp. 185-196, 2007.
20. M. G. Sutton and N. Sharpe, "Left ventricular remodeling after myocardial infarction: pathophysiology and therapy, " Circulation, vol. 101, no. 25, pp. 2981-2988, 2000.
21. J. Wang, W. Huang, R. Xu et al., "MicroRNA-24 regulates cardiac fibrosis aftermyocardial infarction, " Journal of Cellular and Molecular Medicine, vol. 16, no. 9, pp. 2150-2160, 2012.
22. Y. Zhang, Y. Wang, X. Wang et al., "Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21, " Journal of Hypertension, vol. 29, no. 8, pp. 1560-1568, 2011.
23. E. Bostjancic, M. Jerse, D. Glavac, and N. Zidar, "miR-1, miR-133a/b, and miR-208a in human fetal hearts correlate to the apoptotic and proliferation markers, " Experimental Biology and Medicine, vol. 240, no. 2, pp. 211-219, 2015.
24. X. Wang, X. Zhang, X.-P. Ren et al., "MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury, " Circulation, vol. 122, no. 13, pp. 1308-1318, 2010.
25. A. L. Gartel and A. L. Tyner, "The role of the cyclin-dependent kinase inhibitor p21 in apoptosis, " Molecular CancerTherapeutics, vol. 1, no. 8, pp. 639-649, 2002.
26. M. F. van Delft and D. C. S. Huang, "How the Bcl-2 family of proteins interact to regulate apoptosis, " Cell Research, vol. 16, no. 2, pp. 203-213, 2006.
27. R. F. Place, L.-C. Li, D. Pookot, E. J. Noonan, and R. Dahiya, "MicroRNA-373 induces expression of genes with complementary promoter sequences, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 5, pp. 1608-1613, 2008.
28. S. Vasudevan, Y. Tong, and J. A. Steitz, "Switching from repression to activation: microRNAs can up-regulate translation, " Science, vol. 318, no. 5858, pp. 1931-1934, 2007.
29. Y. Shan, J. Zheng, R. W. Lambrecht, and H. L. Bonkovsky, "Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes, " Gastroenterology, vol. 133, no. 4, pp. 1166-1174, 2007.
30. F. See, A. Kompa, J. Martin, D. A. Lewis, and H. Krum, "Fibrosis as a therapeutic target post-myocardial infarction, " Current Pharmaceutical Design, vol. 11, no. 4, pp. 477-487, 2005.
31. B.-W. Wang, G.-J. Wu, W.-P. Cheng, and K.-G. Shyu, "MicroRNA-208a increases myocardial fibrosis via endoglin in volume overloading heart, " PLoS ONE, vol. 9, no. 1, Article ID e84188, 2014.
32. K.-G. Shyu, B.-W. Wang, G.-J. Wu, C.-M. Lin, and H. Chang, "Mechanical stretch via transforming growth factor-beta1 activates microRNA208a to regulate endoglin expression in cultured rat cardiac myoblasts, " European Journal of Heart Failure, vol. 15, no. 1, pp. 36-45, 2013.